[Depression in restless legs syndrome. Pathogenesis, assessment, and implications for treatment]

scientific article published on 01 October 2009

[Depression in restless legs syndrome. Pathogenesis, assessment, and implications for treatment] is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1023536759
P356DOI10.1007/S00115-009-2710-8
P698PubMed publication ID19360385

P50authorJan KassubekQ56956567
Karin Stiasny-KolsterQ30500900
P2093author name stringJ Haan
C Trenkwalder
H Benes
I Peglau
I Eisensehr
M Hornyak
P2860cites workSelective serotonin receptor uptake inhibitors can reduce restless legs symptomsQ73563762
Depression in medically ill hospitalized older adults: prevalence, characteristics, and course of symptoms according to six diagnostic schemesQ73776786
Sex and the risk of restless legs syndrome in the general populationQ34292722
Dopamine and iron in the pathophysiology of restless legs syndrome (RLS).Q34329779
Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adultsQ34386642
Restless legs syndrome prevalence and impact: REST general population studyQ34426489
Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the communityQ34756341
Restless legs syndrome as side effect of second generation antidepressantsQ34777675
Treatment of restless legs syndrome: an evidence-based review and implications for clinical practiceQ34858059
Restless legs syndrome: an update on treatment optionsQ35626330
Depression and Parkinson's disease.Q36022096
Antidepressant medication use and restless legs syndrome in patients presenting with insomniaQ36220871
Restless legs syndrome, periodic limb movements in sleep, and depressionQ36241582
The relationship of depression to cardiovascular disease: epidemiology, biology, and treatmentQ40850649
Impact of sleep-related complaints on depressive symptoms in patients with restless legs syndrome.Q44645849
Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health StudyQ46827321
Bupropion may improve restless legs syndrome: a report of three casesQ46844722
Assessing health-related quality of life in patients with restless legs syndromeQ48439615
Marked reduction in indexes of dopamine metabolism among patients with depression who attempt suicideQ48476780
Treatment of depression in patients with restless legs syndrome: what is evidence-based?Q48507737
Cognitive behavioural group therapy to improve patients' strategies for coping with restless legs syndrome: a proof-of-concept trial.Q51893378
Depression following myocardial infarction. Impact on 6-month survival.Q52032587
[Anhedonia--a general nosology surmounting correlate of a dysfunctional dopaminergic reward system?].Q52175778
"Anxietas tibiarum". Depression and anxiety disorders in patients with restless legs syndrome.Q53279359
P433issue10
P304page(s)1160-6, 1164-6, 1168
P577publication date2009-10-01
P1433published inDer NervenarztQ15446312
P1476title[Depression in restless legs syndrome. Pathogenesis, assessment, and implications for treatment]
P478volume80